"During a press conference in the Oval Office and surrounded by many of his most senior aides, including HHS Secretary Robert Kennedy, Jr, and Dr. Mehmet Oz, Trump revealed that two of the world's largest pharmaceutical manufacturers, Eli Lilly and Novartis, will offer weight loss drugs at drastic discounts. So far, never heard anything bad about them, only good about them, Trump ad libbed from his prepared remarks before asking his Kennedy, Is there anything bad about them, Bobby?"
"These weight loss drugs have proven to be remarkably effective, though also expensive, costing over $1,000 a month for treatment without coverage. Under this new deal, the monthly cost for Wegovy will drop over $1,000 to $250 per month, while Zepbound's monthly cost will dip to $346. Until now, neither of the drugs has been covered by Medicare for weight loss and is rarely covered by Medicaid."
Eli Lilly and Novartis will provide steep discounts on weight-loss drugs Wegovy and Zepbound, reducing monthly costs to $250 and $346 respectively. The drugs previously cost over $1,000 per month without coverage and were rarely covered by Medicare for weight loss and seldom by Medicaid. The price cuts follow reports that Americans paid hundreds to over a thousand percent more for these treatments. The drugs are noted as effective for weight loss and are linked to diabetes treatments under related brand names. The discounts aim to expand access and lower out-of-pocket spending for many patients.
Read at www.mediaite.com
Unable to calculate read time
Collection
[
|
...
]